Toggle Nav
Search
Advanced Search
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research-area stem-cell hippo-signaling'

Search results for: 'research-area stem-cell hippo-signaling'

Shop By
Clear All

Items 1-10 of 39

Page
per page
  1. Cyclopamine
    A8340 Cyclopamine
     1 Citation
    Target: Smoothened
    Summary: Hedgehog (Hh) signaling Inhibitor
      ≥6.9 mg/mL
  2. GDC-0449 (Vismodegib)
    A3021 GDC-0449 (Vismodegib)
     1 Citation
    Target: P-glycoprotein (P-gp)|Hedgehog
    Summary: Hedgehog antagonist,potent and selective
      ≥21.1 mg/mL
      ≥4.96 mg/mL
      insoluble in h2o
  3. Dabrafenib Mesylate (GSK-2118436)
    A3347 Dabrafenib Mesylate (GSK-2118436)
    Target: Raf
    Summary: Inhibitor of BRAF(V600) mutants
      ≥30.75 mg/mL
      ≥2.74 mg/mL
      insoluble in h2o
  4. LY2090314
    A3570 LY2090314
    Target: GSK-3
    Summary: Potent GSK-3 inhibitor
      ≥91 mg/mL
      ≥4.27 mg/mL
      insoluble in h2o
  5. SB202190 (FHPI)
    A1632 SB202190 (FHPI)
     5 Citation
    Target: p38
    Summary: P38 MAPK inhibitor
      ≥57 mg/mL
      ≥22.47 mg/mL
      insoluble in h2o
  6. BYL-719
    A8346 BYL-719
     1 Citation
    Target: PI3K
    Summary: Selective PI3Kα inhibitor
      ≥22.1 mg/mL
  7. LY2228820
    A5566 LY2228820
     1 Citation
    Target: p38
    Summary: P38 MAP kinase inhibitor
      ≥30.65 mg/mL
      ≥9.9 mg/mL
      ≥45 mg/mL
  8. GDC-0879
    A5071 GDC-0879
     1 Citation
    Target: Raf
    Summary: B-Raf inhibitor,potent and selective
      ≥16.7 mg/mL
      insoluble in etoh
      insoluble in h2o
  9. Sorafenib Tosylate
    A8245 Sorafenib Tosylate
     1 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥31.85 mg/mL
      ≥4.15 mg/mL
      insoluble in h2o
  10. TAK-632
    A8226 TAK-632
    Target: Raf
    Summary: Pan-RAF inhibitor,potent and selective
      ≥27.75 mg/mL
      ≥2.23 mg/mL
      insoluble in h2o

Items 1-10 of 39

Page
per page
Shop By
Now Shopping by
  1. Related Disease Melanoma Remove This Item
  2. Related Disease Colorectal Cancer Remove This Item
  3. Related Disease Non-small Cell Lung Cancer Remove This Item
Clear All
Shopping Options
Category
Specificity
  1. Selective 36 items
  2. Non-Selective 1 item
Reversibility
  1. Reversible 1 item
Target
  1. Caspases 1 item
  2. Cyclin-Dependent Kinases 1 item
  3. Histone Deacetylases (HDACs) 2 items
  4. PI3K 1 item
  5. Raf 6 items
  6. Aurora Kinases 1 item
  7. GSK-3 1 item
  8. LPA Receptors 1 item
  9. P-glycoprotein (P-gp) 3 items
  10. PLK 1 item
  11. VEGFR 3 items
  12. PDGFR 1 item
  13. p38 2 items
  14. MEK 2 items
  15. FGFR 1 item
  16. Deubiquitinating enzymes (DUBs) 1 item
  17. Smoothened 1 item
  18. EGFR 2 items
  19. Hedgehog 1 item
  20. p300 1 item
  21. HSP90 1 item
  22. BMI-1 1 item
  23. SGLT 1 item
  24. Sphingosine kinases (SphKs) 1 item
  25. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  26. Vascular Disrupting Agents (VDA) 1 item
Reported Experiments
  1. Animal Experiments 37 items
  2. Cell Experiments 22 items
Related Disease
  1. Acne 1 item
  2. Acute Myelogenous Leukemia 2 items
  3. Acute Myeloid Leukemia 9 items
  4. Autoimmune Diseases 1 item
  5. Bladder Cancer 4 items
  6. B-lymphoid Malignancies 1 item
  7. Breast Cancer 51 items
  8. Cancer 194 items
  9. Cervical Cancer 2 items
  10. Cholangiocarcinoma 1 item
  11. Chronic Lymphocytic Leukemia 2 items
  12. Colon Cancer 23 items
  13. Colon Carcinoma 1 item
  14. Colorectal Cancer 20 items
  15. Diabetes 3 items
  16. Fungal Infection 1 item
  17. Glioblastoma 14 items
  18. Glioma 5 items
  19. HCV 1 item
  20. Hepatocellular Carcinoma 5 items
  21. HIV 3 items
  22. Immunosuppressive Therapy 1 item
  23. Inflammatory Diseases 5 items
  24. Leukemia 12 items
  25. Liver Cancer 3 items
  26. Lung Cancer 14 items
  27. Lymphoma 7 items
  28. Mantle Cell Lymphoma 2 items
  29. Medulloblastoma 1 item
  30. Melanoma 16 items
  31. Mixed Lineage Leukemia 1 item
  32. Multiple Myeloma 8 items
  33. Myeloma 2 items
  34. Neuroblastoma 4 items
  35. Non-small Cell Lung Cancer 9 items
  36. Non-small Cell Lung Carcinoma 1 item
  37. Ovarian Cancer 18 items
  38. Pain Relief 1 item
  39. Pancreatic Cancer 20 items
  40. Pancreatic Carcinoma 2 items
  41. Prostate Cancer 24 items
  42. Psoriasis 2 items
  43. Pulmonary Arterial Hypertension 1 item
  44. Pulmonary Fibrosis 1 item
  45. Renal Cancer 1 item
  46. Renal Cell Carcinoma 3 items
  47. Rheumatoid Arthritis 3 items
  48. Sleep Disorders 1 item
  49. Thyroid Cancer 2 items
  50. Type 2 Diabetes 3 items